💰 Dividend History

No dividend history available.

📅 Earnings & EPS History for IALT

No earnings history available for this symbol.

📰 Related News & Research

• RCM Technologies, Inc. Company Overview: Specialty Healthcare, Engineering, and Life Sciences Solutions & Growth Strategies
  April 4, 2026
  

  RCM Technologies, Inc. Files Annual Report: Key Details for ...

• Cal-Maine Foods Reports Q3 2026 Results: Specialty Eggs and Prepared Foods Drive Diversification Amid Lower Egg Prices
  April 1, 2026
  

  Cal-Maine Foods Fiscal Q3 2026 Results - Investor Report ...

• PMGC Holdings Inc. 2025 Annual Report: Diversified Growth in Biotechnology, Advanced Manufacturing, and Specialty Packaging
  March 30, 2026
  

  PMGC Holdings Inc. 2025 Annual Report: Key Investor Insights...

• Talphera, Inc. (Formerly AcelRx) 2025 Annual Report: Business Overview, Key Risks, and Regulatory Challenges in Specialty Pharmaceuticals
  March 24, 2026
  

  Talphera, Inc. 2025 Annual Report: Investor Analysis & Highl...

• Ascent Solar Technologies: Flexible CIGS Solar Modules for Aerospace, Space, and Specialty Markets – Business Overview & Competitive Strengths 48, 49, 51
  March 21, 2026
  

  Ascent Solar Technologies 2025 Annual Report: Key Highlights...

• SiriusPoint Restructures Business with New Global P&C Programs and London Market Specialty Divisions in 2026
  March 16, 2026
  

  SiriusPoint Announces Major Business Restructuring with Crea...

• Team, Inc. 2025 Annual Report: Leading Global Provider of Specialty Industrial Services, ESG Initiatives, and Business Overview
  March 13, 2026
  

  Team, Inc. Annual Report 2025: Key Insights for Investors ...

• OppFi Inc. 2025 Annual Report: Digital Lending, Financial Inclusion, and Growth Strategies in Specialty Finance
  March 12, 2026
  

  OppFi Inc. 2025 Annual Report: Key Insights and Shareholder ...

• Custom Truck One Source, Inc. 2025 Annual Report: Specialty Equipment Rentals, Sales, and Market Growth Strategies
  March 10, 2026
  

  Custom Truck One Source, Inc. 2025 Annual Report – Key Insig...

• CorMedix Therapeutics 2026: Portfolio Expansion, Financial Highlights, DefenCath Launch & Growth Pipeline in Specialty Pharma 1234567
  March 7, 2026
  

  CorMedix Therapeutics: Corporate Update and Investor Insight...

🔍 View more Reports